← Leaderboards
Donald A Simone
Hillhurst Biopharmaceuticals, Inc.
$12,911,965
Attributed
$17,683,891
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,683,891 · 10
By mechanism
R01$12,360,736 · 5
UG3$2,111,258 · 1
R42$1,858,400 · 1
UH3$728,111 · 1
R21$458,009 · 1
R03$167,377 · 1
Top collaborators
- Kalpna Gupta12 shared
- John D Belcher2 shared
- Edward Gomperts2 shared
- William R Kennedy2 shared
Most similar at Hillhurst Biopharmaceuticals, Inc.
Same institution · by research overlap
- John D Belcher$2,490,337
- Edward Gomperts$8,146,154
Others in their field
Top investigators on “Hyperalgesia”
- Jon David Levine · University Of California, San Francisco$27,557,247
- Kalpna Gupta · University Of Minnesota Twin Cities$16,616,117
- Boris Tabakoff · University Of Colorado Denver$14,836,168
- Bradley K Taylor · University Of Pittsburgh At Pittsburgh$11,999,293
- Frank Porreca · University Of Arizona$11,843,869
- Gerald F Gebhart · University Of Iowa$11,211,662
Research focus
HyperalgesiaPainNociceptorsResponseMechanicsPeripheralNeuronsStimulusNociceptionBehavioralAdverse EffectsAttenuatedNeuropathyCancer PainCellsSkinInterdisciplinary ApproachCannabinoidsAgonistCutaneousNovel StrategiesDoseLeadQuality Of Life
Grant awards (51)
Oral N2O Therapy in Treating Acute Vaso-Occlusive Pain in Sickle Cell Disease$728,111
UH3 · FY2024 · NS
Neural Mechanisms of Cancer Pain$359,693
R01 · FY2023 · CA · contact PI
Oral N2O Therapy in Treating Acute Vaso-Occlusive Pain in Sickle Cell Disease$2,111,258
UG3 · FY2022 · NS
Neural Mechanisms of Cancer Pain$367,614
R01 · FY2022 · CA · contact PI
Neural Mechanisms of Cancer Pain$378,229
R01 · FY2021 · CA · contact PI
The Bumps: A Device for Rapid, Non-Invasive Quantification of Touch Sensation$846,810
R42 · FY2020 · TR
Neural Mechanisms of Cancer Pain$385,080
R01 · FY2020 · CA · contact PI
The Bumps: A Device for Rapid, Non-Invasive Quantification of Touch Sensation$1,011,590
R42 · FY2019 · TR
Cannabinoid Modulation of Hyperalgesia$488,499
R01 · FY2019 · HL · contact PI
Neural Mechanisms of Cancer Pain$436,110
R01 · FY2019 · CA · contact PI
Cannabinoid Modulation of Hyperalgesia$488,499
R01 · FY2018 · HL · contact PI
Cannabinoid Modulation of Hyperalgesia$489,124
R01 · FY2017 · HL · contact PI
Cannabinoid Modulation of Hyperalgesia$493,069
R01 · FY2016 · HL · contact PI
Cannabinoid Modulation of Hyperalgesia$357,453
R01 · FY2014 · DA · contact PI
Characteristics and mechanisms of pain in sickle cell disease$21,634
R01 · FY2014 · HL
Characteristics and mechanisms of pain in sickle cell disease$8,238
R01 · FY2014 · HL
Characteristics and mechanisms of pain in sickle cell disease$430,237
R01 · FY2013 · HL
Cannabinoid Modulation of Hyperalgesia$337,209
R01 · FY2013 · DA · contact PI
Characteristics and mechanisms of pain in sickle cell disease$22,428
R01 · FY2013 · HL
Characteristics and mechanisms of pain in sickle cell disease$492,012
R01 · FY2012 · HL
Cannabinoid Modulation of Hyperalgesia$351,505
R01 · FY2012 · DA · contact PI
Functional Interactions between Cancer Cells and Sensory Neurons$53,791
R03 · FY2012 · TW · contact PI
Characteristics and mechanisms of pain in sickle cell disease$492,751
R01 · FY2011 · HL
Cannabinoid Modulation of Hyperalgesia$354,444
R01 · FY2011 · DA · contact PI
Neural Mechanisms of Cancer Pain$226,673
R01 · FY2011 · CA · contact PI
Functional Interactions between Cancer Cells and Sensory Neurons$53,791
R03 · FY2011 · TW · contact PI
Characteristics and mechanisms of pain in sickle cell disease$14,756
R01 · FY2011 · HL
Characteristics and mechanisms of pain in sickle cell disease$458,380
R01 · FY2010 · HL
Cannabinoid Modulation of Hyperalgesia$350,968
R01 · FY2010 · DA · contact PI
Neural Mechanisms of Cancer Pain$234,297
R01 · FY2010 · CA · contact PI
A New Device for Rapid Measurement of Touch Sensation in neuropathy$209,484
R21 · FY2010 · NS · contact PI
Functional Interactions between Cancer Cells and Sensory Neurons$59,795
R03 · FY2010 · TW · contact PI
Cannabinoid Modulation of Hyperalgesia$277,835
R01 · FY2009 · DA · contact PI
A New Device for Rapid Measurement of Touch Sensation in neuropathy$248,525
R21 · FY2009 · NS · contact PI
Neural Mechanisms of Cancer Pain$230,146
R01 · FY2009 · CA · contact PI
Cannabinoid Modulation of Hyperalgesia$277,835
R01 · FY2008 · DA · contact PI
Neural Mechanisms of Cancer Pain$223,889
R01 · FY2008 · CA · contact PI
Cannabinoid Modulation of Hyperalgesia$283,506
R01 · FY2007 · DA · contact PI
Neural Mechanisms of Cancer Pain$241,751
R01 · FY2007 · CA · contact PI
Cannabinoid Modulation of Hyperalgesia$291,974
R01 · FY2006 · DA · contact PI
Cannabinoid Modulation of Hyperalgesia$261,625
R01 · FY2005 · DA
Neural Mechanisms of Cancer Pain$230,953
R01 · FY2005 · CA
Neural Mechanisms of Cancer Pain$230,969
R01 · FY2004 · CA
CANNABINOID MODULATION OF HYPERALGESIA$221,833
R01 · FY2004 · DA
Neural Mechanisms of Cancer Pain$230,984
R01 · FY2003 · CA
CANNABINOID MODULATION OF HYPERALGESIA$215,562
R01 · FY2003 · DA
Neural Mechanisms of Cancer Pain$230,999
R01 · FY2002 · CA
CANNABINOID MODULATION OF HYPERALGESIA$217,400
R01 · FY2002 · DA
Neural Mechanisms of Cancer Pain$229,517
R01 · FY2001 · CA
CANNABINOID MODULATION OF HYPERALGESIA$210,254
R01 · FY2001 · DA
CANNABINOID MODULATION OF HYPERALGESIA$214,802
R01 · FY2000 · DA